Indefinite Delivery Contract 36C26122D0019

Award Date 10/1/21
Last Date to Order 9/30/24
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
RLS USA Inc. was awarded an indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 to provide radiopharmaceutical products. The potential value of the contract is $1,162,500. No set-aside designation was applied. Under the contract, RLS USA Inc. received two delivery orders to date for radiopharmaceutical supplies. The first delivery order, valued at $244,564.67, was awarded on August 2, 2022 for a performance...
This federal Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the delivery of non-positron emission tomography (non-PET) radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. The contract has a performance period from April 1, 2025, to March 31, 2026, with a ceiling value of $425,725.07. RLS (USA) Inc. is an experienced federal...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a single award indefinite delivery contract to RLS USA Inc. to provide radiopharmaceutical products and services to the Milwaukee VA Medical Center. The contract has a total value of $648,785.97 to be delivered over a three year period of performance from March 1, 2023 through February 28, 2026. RLS USA Inc. will supply radiopharmaceuticals from its place of performance in Lake...
This single-award Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, to provide radiopharmaceuticals and related supplies to the VA Northern California Health Care System (VANCHCS). The contract has a ceiling value of $2,500,000 and a performance period through March 31, 2030. Under this IDC, RLS (USA) Inc. will deliver radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18,...
This Indefinite Delivery Contract (IDC) was awarded by the Veterans Integrated Service Network 5 (VISN 5), a component of the U.S. Department of Veterans Affairs (VA), to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract has a ceiling value of $2,162,919.87 and a period of performance extending to March 31, 2030. The contract is for the provision of radiopharmaceuticals, which are critical for nuclear medicine diagnostic services at VA medical centers. RLS (USA)...
This federal contract IDV award is a single-award indefinite delivery contract between the U.S. Department of Veterans Affairs (VA) and the prime contractor RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract has a total ceiling value of $249,500 and a performance period ending on March 31, 2025. Under this IDV, RLS (USA) Inc. will supply a variety of non-PET radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers and military...
The Defense Health Agency awarded RLS USA Inc. a single award indefinite delivery contract for radiopharmaceuticals with a potential value of $1,914,116.40 over five years. No set-aside provisions were applied. Under this vehicle, RLS USA Inc. received a firm fixed price delivery order for $299,975.67 to supply unspecified radiopharmaceutical products to the Defense Health Agency from their Tampa, Florida facility between November 2022 through September 2023. Additionally, a $64,238.93 order was...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a single award indefinite delivery contract to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, to provide nuclear radiopharmaceuticals medicine. The contract has a potential value of $950,000 and period of performance from June 10, 2022 through September 30, 2026. Under the contract, the awardee has been issued three firm fixed price delivery orders...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery indefinite quantity contract with a potential value of $2.2 million to Sierra Radiopharmacy LLC of Reno, Nevada. The contract provides for the delivery of radiopharmaceuticals to support nuclear medicine procedures at VA medical facilities in Reno. Three firm fixed price delivery orders have been issued against the contract to date, valued at $751,665, $655,070,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded an indefinite-delivery contract to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, to provide single dose radiopharmaceuticals in support of nuclear medicine services. Over the period of performance from March 2020 to February 2025, the contract established a total potential value of $2,664,954.52. Delivery orders issued against this contract vehicle from 2020...
  • 36C26122D0019
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery contract to RLS USA Inc. to provide non-PET radiopharmaceuticals in support of nuclear medicine services. The contract established a potential value of $733,420.11 over its period of performance from October 2021 through September 2024. Delivery orders issued against this contract included awards of $251,729.90, $244,402.04, and $650,585.28 to RLS USA Inc. for the provision of non-PET radiopharmaceuticals to the Palo Alto VA Medical Center in Lake Zurich, Illinois and the Veterans Affairs Palo Alto Health Care System in Palo Alto, California. These orders required delivery of the requested products between October 2023 to September 2024, October 2022 to September 2023, and October 2021 to September 2022 respectively. The originating pre-solicitation notice indicated the Department of Veterans Affairs intended to award an indefinite delivery contract for these purposes on behalf of its health care facilities in Northern California, Nevada, and Hawaii to efficiently meet nuclear medicine needs.

The delivery orders awarded against this contract were firm-fixed price and no subcontractors or socioeconomic set-asides were identified. The purpose of these contracted products and services is to support nuclear medicine diagnostic services for veterans through the delivery of non-PET radiopharmaceuticals to VA medical centers and health care systems in the specified region.

Generated 1/5/24, 9:46 PM